The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

In conjunction with our colloquium given by Prof. Link on ALS, please join us in the IPHY ALS Ice Bucket Challenge to help support research on this disease.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that preclinical research exploring key mechanisms underlying amyotrophic lateral sclerosis (ALS) pathology will be presented at the 2025 ...